Filing Details
- Accession Number:
- 0000899243-21-022987
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-10 17:00:54
- Reporting Period:
- 2021-06-09
- Accepted Time:
- 2021-06-10 17:00:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703057 | Abcellera Biologics Inc. | ABCL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1844479 | Ester Falconer | C/O Abcellera Biologics Inc. 2215 Yukon Street Vancouver A1 V5Y 0A1 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2021-06-09 | 1,000,000 | $25.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- On June 9, 2021, the shares were sold in connection with a private sale transaction at a per share price of $25.50.
Billionaire Hedge Funds
